Evidence map›Paper›PMID 41073394›Full record

ArticleTranslational psychiatry2025

Cannabinoid CB1 receptor in dopaminergic circuit from ventral tegmental area to nucleus accumbens links trait anxiety with reward learning.

Chi Cui, Gangan Luo, Jie Lei, Yulong Shi, Yibo Yao, Kun Ren, Jian Yang, Tongxia Li, Ming Li, Xiang Peng and 5 more

Abstract read
In one paragraph

Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Chi Cui *Hubei Provincial Clinical Research Center for Alzheimer's Disease, Tianyou Hospital, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, P.R. China.
Gangan Luo *Department of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Jie LeiDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Yulong ShiDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Yibo YaoDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Kun RenDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Jian YangDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Tongxia LiDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Ming LiDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Xiang PengDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Xueke YangDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Junsong DuDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Sitong ChenDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China.
Bo TianHubei Provincial Clinical Research Center for Alzheimer's Disease, Tianyou Hospital, School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, P.R. China. tianbo@wust.edu.cn.
Pei ZhangDepartment of Neurobiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, P. R. China. zhangpei@hust.edu.cn.ORCID http://orcid.org/0000-0003-0608-5677

Funding

National Natural Science Foundation of China (National Science Foundation of China) no. 31871073National Natural Science Foundation of China (National Science Foundation of China) no. 32171023National Natural Science Foundation of China (National Science Foundation of China) no. 32271036
6 · The paper itself

Abstract

The endocannabinoid (eCB) system has risen as a critical modulator linking the environmental challenges to behavioral maladaptation, such as trait anxiety and reward learning impairment. However, the association between trait anxiety and reward learning and how they share molecular mechanism in eCB system is still unknown. Here, we utilized a series of behavioral tests to screen the correlation among the behavioral patterns, especially between trait anxiety and reward learning. The elevated platform stress and open field test (OFT) were employed to classify the mice into the different level of trait anxiety, and ethanol-induced conditioned place preference (CPP) was used to assess the ability of reward learning. Our results indicated that high trait anxiety (HTA) mice exhibited increased reward learning. Intracranial administration of the cannabinoid CB1 receptor (CB1R) antagonist AM-251 or agonist WIN55,212-2 in nucleus accumbens (NAc) showed the different effect on anxiety-like behavior and reward learning. Similarly, CB1R knockout in VTA dopaminergic (VTA

Indexed as

AnxietyDopaminergic NeuronsNucleus AccumbensReceptor, Cannabinoid, CB1RewardVentral Tegmental AreaAnimalsBehavior, AnimalBenzoxazinesMaleMiceMice, Inbred C57BLMice, KnockoutMorpholinesNaphthalenesPiperidines(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneAM 251BenzoxazinesMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1

Identifiers

PMID41073394
PMCPMC12514215

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.